REQUEST A QUOTE
REQUEST A QUOTE

Google Search

Search

Already a Member ?

Register Now!

Best Business Opportunities in Yemen, Middle East - Identification and Selection of right Project, Thrust areas for Investment, Industry Startup and Entrepreneurship

We can provide you detailed project reports on the following topics. Please select the projects of your interests.

Each detailed project reports cover all the aspects of business, from analysing the market, confirming availability of various necessities such as plant & machinery, raw materials to forecasting the financial requirements. The scope of the report includes assessing market potential, negotiating with collaborators, investment decision making, corporate diversification planning etc. in a very planned manner by formulating detailed manufacturing techniques and forecasting financial aspects by estimating the cost of raw material, formulating the cash flow statement, projecting the balance sheet etc.

We also offer self-contained Pre-Investment and Pre-Feasibility Studies, Market Surveys and Studies, Preparation of Techno-Economic Feasibility Reports, Identification and Selection of Plant and Machinery, Manufacturing Process and or Equipment required, General Guidance, Technical and Commercial Counseling for setting up new industrial projects on the following topics.

Many of the engineers, project consultant & industrial consultancy firms in India and worldwide use our project reports as one of the input in doing their analysis.

We can modify the project capacity and project cost as per your requirement.
We can also prepare project report on any subject as per your requirement.

Page 11 of 53 | Total 523 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 .... 52 53   Next »

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Select all | Clear all Sort by

Active Pharma Ingredients • Azithromycin • Cefixime • Telmisartan • Diclofenac sodium • Acecloflenac

Active pharmaceutical ingredients are the active substances that are used in the manufacture of a drug and have a pharmacological effect. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. Active pharmaceutical ingredients may be synthesized either chemically or through biotechnological methods. The Active Pharmaceutical Ingredient (API) is the part of any drug that produces the intended effects. Some drugs, such as combination therapies, have multiple active ingredients to treat different symptoms or act in different ways. Active pharmaceutical ingredient (API), is the term used to refer to the biologically active component of a drug product (e.g. tablet, capsule). Drug products are usually composed of several components. The aforementioned API is the primary ingredient. Other ingredients are commonly known as "excipients" and these substances are always required to be biologically safe, often making up a variable fraction of the drug product. The procedure for optimizing and compositing this mixture of components used in the drug is known as "formulation." The global active pharmaceutical ingredient market size is expected to reach a value of USD 286.6 billion by 2027, registering a CAGR of 6.7% over the forecast period. Factors, such as increasing preference for outsourcing APIs and growing prevalence of various target diseases such as cancer and Cardiovascular Diseases (CVDs) are expected to drive the market growth. The Asia Pacific is expected to emerge as the fastest-growing regional market due to rapidly increasing the prevalence of therapeutic and chronic diseases i.e., diabetes, cancer etc. with rising population in this region. According to WHO, around 65% of all cancer deaths occur in developing countries and the number of global cancer deaths is projected to increase by 45 percent from 2007 to 2030 with from 7.9 million to 11.5 million deaths influenced by rise in consumption of tobacco use, unhealthy diet, insufficient physical activity and the harmful use of alcohol in this region. The active pharmaceutical ingredients market gets a major boost from the growing prevalence of cardiovascular conditions, infectious diseases, and various other chronic disorders. Other than these, the rise in various genetic disorders has driven the use of biologicals and biosimilars, the world over. In many instances, biosimilars are the most preferred owing to them being low-cost. Biosimilars have the potential of creating a highly sustainable healthcare system which makes way for innovation, allowing more patients to receive the optimum care. Thus, due to demand it is best to invest in this project. Few Indian major players are as under Alpha Remedies Ltd. Ankur Drugs & Pharma Ltd. Aurobindo Pharma Ltd. Farmson Pharmaceutical Gujarat Pvt. Ltd. Glaxosmithkline Pharmaceuticals Ltd. Sanofi India Ltd. Piramal Enterprises Ltd. Teva Pharmaceutical & Chemical Inds. India Pvt. Ltd.
Plant capacity: Azithromycin: 500 Kgs / Day Cefixime: 500 Kgs / Day Telmisartan: 50 Kgs / Day Diclofenac Sodium: 500 Kgs / Day Aceclofenac: 500 Kgs / DayPlant & machinery: Rs 155 lakhs
Working capital: -T.C.I: Cost of Project : Rs 729 lakhs
Return: 31.00%Break even: 61.00%
Add to Inquiry Add to Inquiry Basket

Lithium Ion Battery (Battery Assembly)

Lithium batteries are now powering a wide range of electrical and electronically devices, including laptop computers, mobile phones, power tools, telecommunication systems and new generations of electric cars and vehicles. Lithium metal batteries and lithium ion batteries. Basically, the difference between them is that lithium metal batteries are those that are not rechargeable, thus, primary, and lithium ion batteries are those that can be recharged. As an example, your laptop or cell phone is likely to have a lithium ion battery, whereas your watch may have a lithium metal battery. The India lithium-ion battery market is expected to grow at a robust CAGR of 29.26% during the forecast period, 2018-2023. The Indian automobile sector is one of the most prominent sectors of the country, accounting for nearly 7.1% of the national GDP. The industry produced a total of 25.31 million vehicles, including commercial, passenger, two, and three vehicles and commercial quadricycle in April-March 2017, as against 24.01 million in April-March 2016. However, India has set itself an ambitious target of having only electric vehicles (EV) by 2030, which is expected to increase the demand for lithium-ion batteries in India, significantly. “In the coming years, India is expected to witness substantial investments by various companies to set up their Li-ion battery manufacturing base in the country. Entrepreneurs who invest in this project will be successful. Few Indian major players are as under H B L Power Systems Ltd. Luminous Power Technologies Pvt. Ltd. Okaya Power Pvt. Ltd. Eon Electric Ltd. Carborundum Universal Ltd. Bharat Electronics Ltd.
Plant capacity: 48 Volt, 60 AH Lithium-Ion Battery Pack : 5 Nos / Day 48 Volt, 80 AH Lithium-Ion Battery Pack : 5 Nos / Day 48 Volt, 100 AH Lithium-Ion Battery Pack : 5 Nos / Day 60 Volt, 20 AH Lithium-Ion Battery Pack : 5 Nos / Day 60 Volt, 30 AH Lithium-Ion Battery PacPlant & machinery: Rs 306 lakhs
Working capital: -T.C.I: Cost of Project : Rs 648 lakhs
Return: 28.00%Break even: 62.00%
Add to Inquiry Add to Inquiry Basket

Azithromycin, Cefixime, Telmisartan, Diclofenac Sodium, Acecloflenac Manufacturing. Production of Active Pharma Ingredients (API).

Azithromycin, Cefixime, Telmisartan, Diclofenac Sodium, Acecloflenac Manufacturing. Production of Active Pharma Ingredients (API). Opportunities for Entrepreneurs to Start Own Industry. The active pharmaceutical ingredient (API) is the part of any drug that produces the intended effects. Some drugs, such as combination therapies, have multiple active ingredients to treat different symptoms or act in different ways. Active pharmaceutical ingredients are the active substances that are used in the manufacture of a drug and have a pharmacological effect. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. Active pharmaceutical ingredients may be synthesized either chemically or through biotechnological methods. Related Project: - Active Pharma Ingredients • Azithromycin • Cefixime • Telmisartan • Diclofenac Sodium • Acecloflenac Active Pharmaceutical Ingredient (API) is the portion of drug that generates intentional effects. APIs are biologically and chemically active constituents of medicines with direct effect in mitigation, prevention, cure and treatment of diseases. Some of the medicines like combination therapies have many active ingredients to treat diverse symptoms or perform in numerous ways. Active Pharmaceutical Ingredient has active ingredient that is contained in medicine. For illustration, an active ingredient to reduce pain is incorporated in a painkiller. A slight amount of the active ingredient has result thus only small part of the active ingredient is confined in medicine. Role of Government towards API The coronavirus outbreak disrupting supply of active pharmaceutical ingredients (APIs) and medical devices from China to India, the government has come out with four schemes worth Rs 13,760 crore to encourage manufacturing of bulk drugs and medical devices in the country and their exports. On March 21, the Union Cabinet under the chairmanship of Prime Minister Narendra Modi had approved an expenditure of Rs. 9,940 crore and Rs. 3,820 crore for APIs and medical devices, respectively. Related Videos: - Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates, Pharmaceutical Drugs, Pharma Drug Ingredients Intermediates, Pharmaceutical Bulk Drugs The Cabinet also approved a scheme on promotion of bulk drug parks for financing common infrastructure facilities in three bulk drug parks with financial implication of Rs. 3,000 crore for next five years. The government will give grants-in-aid to states with a maximum limit of Rs. 1,000 crore per bulk Drug Park. Parks will have common facilities such as solvent recovery plant, distillation plant, power and steam units, common effluent treatment plant etc. The government further approved production linked incentive (PLI) scheme for promotion of domestic manufacturing of critical KSMs/drug intermediates and APIs in the country with financial implications of Rs. 6,940 crore for next eight years. Financial incentive will be given to eligible manufacturers of identified 53 critical bulk drugs on their incremental sales over the base year (2019-20) for a period of 6 years. Out of 53 identified bulk drugs, 26 are fermentation based bulk drugs and 27 are chemical synthesis based bulk drugs. Rate of incentive will be 20 per cent (of incremental sales value) for fermentation based bulk drugs and 10 per cent for chemical synthesis based bulk drugs. The PLI scheme will lead to expected incremental sales of Rs. 46,400 crore and significant additional employment generation over eight years. The drug industry has welcomed the incentives offered by the government to promote API units in India. Besides APIs, the Cabinet also approved the scheme for promotion of medical device parks in the country in partnership with the states. A maximum grant-in-aid of Rs. 100 crore per park will be provided to the states. It will have financial implications of Rs. 400 crore. The PLI scheme for promoting domestic manufacturing of medical devices will have financial implications of Rs. 3,420 crore for next five years. Medical device is a growing sector and its potential for growth is the highest among all sectors in the healthcare market. It is valued at Rs. 50,026 crore for 2018-19 and is expected to reach to Rs. 86,840 crore by 2021-22. India depends on imports up to an extent of 85 per cent of total domestic demand of medical devices. Union Cabinet scheme on Promotion of Bulk Drug Parks • The scheme on Promotion of Bulk Drug Parks for financing Common Infrastructure Facilities in 3 Bulk Drug Parks with financial implication of Rs. 3,000 crore for next five years. • Production Linked Incentive (PLI) Scheme for promotion of domestic manufacturing of critical KSMs/Drug Intermediates and APIs in the country with financial implications of Rs6,940 crore for next eight years. Details: Promotion of Bulk Drug Parks • Decision is to develop 3 mega Bulk Drug parks in India in partnership with States. • Government of India will give Grants-in-Aid to States with a maximum limit of Rs. 1000 Crore per Bulk Drug Park. • Parks will have common facilities such as solvent recovery plant, distillation plant, power & steam units, common effluent treatment plant etc. • A sum of Rs. 3,000 crore has been approved for this scheme for next 5 years. Production Linked Incentive Scheme • Financial incentive will be given to eligible manufacturers of identified 53 critical bulk drugs on their incremental sales over the base year (2019-20) for a period of 6 years. • Out of 53 identified bulk drugs, 26 are fermentation based bulk drugs and 27 are chemical synthesis based bulk drugs. • Rate of incentive will be 20 % (of incremental sales value) for fermentation based bulk drugs and 10% for chemical synthesis based bulk drugs. • A sum of Rs. 6,940 crore has been approved for next 8 years. Market Outlook Active Pharmaceutical Ingredients Market Dynamics The growing cases of chronic diseases are one of the leading causes of hospitalization, and a majority of the patients with these conditions may need re-admission in hospitals due to infection leading to other chronic diseases. For instance, according to the report published by the Centers for Disease Control and Prevention (CDC), nearly 92.1 million adults in the US dealt with at least one type of cardiovascular disease in 2017. Besides, CDC has also stated that out of the total annual healthcare expenditure, i.e., USD 27 trillion, 86% is for the people with chronic health conditions in the US. Some of the prime factors spurring the growth of the market are increasing occurrences of cardiovascular, oncology, lifestyle and diabetes diseases, intensifying number of diagnostic centers and hospitals and escalating elderly population in emerging countries. Furthermore, cumulative healthcare spending, growing disease responsiveness and education are propelling the growth of the market. Related Projects: - Active Pharmaceutical Ingredient (API) Products, Bulk API Manufacturing With advancements in healthcare infrastructure, healthcare spending has increased over time. This augmenting focus on healthcare spending positively influences the market for active pharmaceutical ingredients. The high adoption rate of generic drugs in developed and developing economies is fueling the growth of the market. Another positive impact comes from the high demand for specialty medicines which is anticipated to escalate the spending in the pharmaceutical sector. Developed nations are expected to exhibit faster growth in these spending as compared to the developing economies on the back of factors such as the presence of adequate manufacturing units, transparent pricing, and higher spending power. Specialty medicines a trend in the active pharmaceutical ingredients market A higher generic adoption rate in developed countries that ranges from 27% to 32% is driving global medicine spending and aiding greater access to improved, lifesaving healthcare services. The adoption of branded generic drugs is predicted to be higher in emerging economies such as China and India and generic drugs accounted for nearly 80% of the total drugs sold by value in these fast-growing nations in 2016. Rising use of specialty medicines is anticipated to grow the pharmaceutical spending worldwide with quicker growth in richer, developed nations as compared to their emerging counterparts. This is primarily because the former have adequate manufacturing units, a higher spending power, and greater emphasis on transparent pricing by assessing measuring effects on the population. Related Books: - Pharmaceutical, Drugs, Proteins Technology Handbooks Active pharmaceutical ingredient (API), is the term that is used to refer to the biologically active component of a drug (e.g. tablet, capsule). A drug is usually composed of several components. The API represents the primary ingredient. Other ingredients are commonly known as "excipients. Sometimes a drug can contain several APIs and its effect on a patient depends on the dosage prescribed and can vary from person to person. In combination therapies, two or more than two active ingredients are used to treat different symptoms in different ways. Stringent quality control is a mandate when it comes to the manufacturing of drugs as the API represents the main component considered while making the prescription. The global active pharmaceutical ingredient market size is expected to reach a value of USD 286.6 billion by 2027, registering a CAGR of 6.7% over the forecast period. Factors, such as increasing preference for outsourcing APIs and growing prevalence of various target diseases such as cancer and Cardiovascular Diseases (CVDs) are expected to drive the market growth. Related Videos: - Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates, Pharmaceutical Drugs, Pharma Drug Ingredients Intermediates, Pharmaceutical Bulk Drugs The major factors driving the overall growth of the APIs market in this region include the growing incidence of preventable chronic diseases, increasing government focus on generic drugs, rising demand for biologics and specialty drugs, and technological advancements in the manufacturing processes of APIs. This market segment is expected to grow at a modest rate due to a combination of economic and healthcare severity measures and the introduction of low-cost, generic versions of branded drugs. Key Players:- Alpha Remedies Ltd. Ankur Drugs & Pharma Ltd. Aurobindo Pharma Ltd. Cian Healthcare Ltd Cipla Ltd. Dr. Reddy'S Laboratories Ltd. Farmson Pharmaceutical Gujarat Pvt. Ltd. Glaxosmithkline Pharmaceuticals Ltd. Indoco Remedies Ltd. Pan Drugs Ltd. Piramal Enterprises Ltd. Sanofi India Ltd. Sri Krishna Pharmaceuticals Ltd. Teva Pharmaceutical & Chemical Inds. India Pvt. Ltd. Triton Laboratories Ltd. Tags: - #APIBusiness #apimanufacturing #Apiproduction #APImarket #APIProject #ApiStartup #APIindustry #Activepharmaingredients #pharmaingredients #IndianPharma, #medicineingredients #CoronavirusBusiness #COVID2019 #Activepharmaingredientbusinessplan #APIbusinessplan #APIbusinessidea #startupAPIbusiness #Activepharmaingredientmanufacturing #APIproduction #API #Azithromycin #Cefixime #Telmisartan #Diclofenacsodium #Acecloflenac #DetailedProjectReport #businessconsultant #BusinessPlan #feasibilityReport #NPCS #entrepreneurindia #startupbusiness #startupbusinessideas #howtostartbusiness #InvestInStartups #Plan4Business #StartupProject #ProjectReport #startupplan #BusinessKaiseshurukare #BusinessProjectReport
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Manufacturing of Ciprofloxacin Hydrochloride (CIPRO) - Active Pharma Ingredient

Manufacturing of Ciprofloxacin Hydrochloride (CIPRO) - Active Pharma Ingredient. Investment Opportunity for Startups and Entrepreneurs. Ciprofloxacin is an antibiotic agent in the fluoroquinolone class used to treat bacterial infections such as urinary tract infections and pneumonia. Ciprofloxacin is FDA approved for the treatment of urinary tract infections, sexually transmitted infections (gonorrhea and cancroid), skin, bone and joint infections, prostatitis, typhoid fever, gastrointestinal infections, lower respiratory tract infections, anthrax, plague, and salmonellosis. Related Projects: - Active Pharmaceutical Ingredient (API) Products, Bulk API Manufacturing Uses and Applications Ciprofloxacin only treats bacterial infections; it does not treat viral infections such as the common cold. For certain uses including acute sinusitis, lower respiratory tract infections and uncomplicated gonorrhea, ciprofloxacin is not considered a first-line agent. This antibiotic treats only bacterial infections. It will not work for virus infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Mycoplasma contamination is a major problem in cell culture in biomedical and biopharmaceutical research, with rates near 15-30%. While there is no method for visual confirmation of mycoplasma, contamination has serious effects on key characteristics and functions of cells, thus compromising any research done. Cipro (ciprofloxacin hydrochloride) is the standard antibiotic for rapid and efficient decontamination. Related Books: - Pharmaceutical, Drugs, Proteins Technology Handbooks CIPRO is indicated in adult patients for treatment of complicated intra-abdominal infections (used in combination with metronidazole) caused by Escherichia coli, Pseudomonas aeruginosa, Proteus mirabilis, Klebsiella pneumoniae, or Bacteroides fragilis. Ciprofloxacin (Cetraxal, Ciloxan, and Cipro) is an inexpensive drug used to treat certain bacterial infections. It is more popular than comparable drugs. Application Urogenital Infections Respiratory Tract Infections Gastrointestinal Infections Typhoid Bone and Joint Infections Skin and Soft Tissue Infections Sepsis and Other Systemic Infections Related Videos: - Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates, Pharmaceutical Drugs, Pharma Drug Ingredients Intermediates, Pharmaceutical Bulk Drugs Government Initiatives • Some of the initiatives taken by the Government to promote the pharmaceutical sector in India are as follows: • India plans to set up a nearly Rs 1 lakh crore (US$ 1.3 billion) fund to provide boost to companies to manufacture pharmaceutical ingredients domestically by 2023. • In November 2019, the Cabinet approved extension/renewal of extant Pharmaceuticals Purchase Policy (PPP) with the same terms and conditions while adding one additional product namely, Alcoholic Hand Disinfectant (AHD) to the existing list of 103 medicines till the final closure/strategic disinvestment of Pharma CPSUs. • Under Budget 2020-21, Rs 65,012 crore (US$ 9.30 billion) has been allocated to the Ministry of Health and Family Welfare is. The Government has allocated Rs 34,115 crore (US$ 4.88 billion) towards the National Health Mission under which rural and urban people will get benefited. • Rs 6,400 crore (US$ 915.72 million) has been allocated to health insurance scheme Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana (AB-PMJAY). • As per Economic Survey 2019-20, Government expenditure (as a percentage of GDP) increased to 1.6 per cent in FY20 from 1.2 per cent in FY15 on health. Related Projects: - Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates • The National Health Protection Scheme is the largest Government funded healthcare programme in the world, which is expected to benefit 100 million poor families in the country by providing a cover of up to Rs 5 lakh (US$ 7,723.2) per family per year for secondary and tertiary care hospitalisation. The programme was announced in Union Budget 2018-19. • The Government of India is planning to set up an electronic platform to regulate online pharmacies under a new policy to stop any misuse due to easy availability. • Government of India unveiled 'Pharma Vision 2020' to make India a global leader in end-to-end drug manufacture. Approval time for new facilities has been reduced to boost investment. • India has imposed a provisional anti-dumping duty on imports of Ciprofloxacin Hydrochloride from China on the grounds that it was hurting domestic industry, following an investigation of the Directorate General of Trade Remedies (DGTR). • The department of revenue issued a notification to the effect on September 2, imposing a duty ranging between $0.94 and $3.29 per kg coming from China. • Ciprofloxacin Hydrochloride is used to treat different types of bacterial infections and certain types of diarrhea. The DGTR had initiated the investigation in January this year. Related Videos: - Industrial, Medical and Specialty Gases Manufacturing Project Ideas Market Outlook The India ciprofloxacin market is segmented based on composition, source, and form, route of administration, distribution channel, application, end user, company and region. Based on route of administration, the market can be categorized into oral, ophthalmic, optic, and intravenous and others. The intravenous segment is expected to witness significant growth through FY2026. This can be ascribed to the use of this route of administration for the drugs which are not absorbed after consumption through oral route. Additionally, large quantities of drug can be administered using this route of drug administration with 100% bioavailability. The Global Ciprofloxacin Market is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2020 to 2027. Related Project:- Ciprofloxacin Hydrochloride Indian pharmaceutical sector is expected to grow to US$ 100 billion, while medical device market is expected to grow US$ 25 billion by 2025. Pharmaceuticals export from India stood at US$ 20.70 billion in FY20. Pharmaceutical export include bulk drugs, intermediates, drug formulations, biological, Ayush and herbal products and surgical. The remaining of the active pharmaceutical ingredient of ciprofloxacin is being dispersed in another combination product and specifically utilize in the urinary tract antibiotic only. Thereby anticipated to lure the new market players in the ciprofloxacin market. The higher incidence of skin and immunological disorder is anticipated to offer a steady revenue generation opportunity in the ciprofloxacin market. Increase awareness about safe drug utilization, however increase in adverse drug reaction awareness and stringent government impositions have narrowed the growth path for global Ciprofloxacin market in North America. Furthermore in East Asia region considerably higher market growth rate is expected due to higher utilization of ciprofloxacin in renal infection in the region. Thereby anticipated to increase the revenue generation in the Ciprofloxacin market. Related Projects: - Chemicals (Organic, Inorganic, Industrial) Projects The bulk drugs segment continues to be the highest revenue generating segment for the Indian pharma industry. It accounts for production worth Rs 120 bn and contributes about 36% of the total pharma exports. India produces 400 bulk drugs through its 1,300 licensed bulk drug units that cater to most of the domestic bulk drug requirements. Related Projects: - Active Pharma Ingredients(API) Key Players:- ? Aarti Drugs Ltd. ? Aurobindo Pharma Ltd. ? Cipla Ltd. ? Indoco Remedies Ltd. ? Kores (India) Ltd. ? Mylan Pharmaceuticals Pvt. Ltd. ? Neuland Laboratories Ltd. ? S S Organics Ltd ? Smruthi Organics Ltd. ? Sreepathi Pharmaceuticals Ltd. ? Sterling Basic Organics Ltd. ? Sun Pharma Laboratories Ltd. ? Sun Pharma Medisales Pvt. Ltd. ? Wockhardt Ltd. Tags:- #CiprofloxacinHydrochloride #Ciprofloxacin #CiprofloxacinBusinessPlan #activepharmaceuticalingrediants #activepharmaingredient #Pharmaceutical #pharmaindustry #APIManufacturing #APIProduction #APImarket #APIBusiness #APIbusinessplan #startupAPIbusiness #CIPRO #startyourbusiness #investmentopportunity #covidbusiness #DetailedProjectReport #businessconsultant #BusinessPlan #feasibilityReport #NPCS #bussinessplanshub #Startupbusiness4you #StartupBusinessPlan #startupinvestment #startup #ChemicalIndustry
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Micronutrients Fertilizer

Micronutrient-efficient varieties grow deeper roots in mineral deficient soils and are better at tapping subsoil water and minerals. When topsoil dries, roots in the dry soil zone (which are the easiest to fertilizer) are largely deactivated and the plant must rely on deeper roots for further nutrition. The micronutrients are boron (B), copper (Cu), iron (Fe), manganese (Mn), molybdenum (Mo), zinc (Zn), and chloride (Cl). Micronutrient-efficient varieties grow deeper roots in mineral deficient soils and are better at tapping subsoil water and minerals. When topsoil dries, roots in the dry soil zone (which are the easiest to fertilizer) are largely deactivated and the plant must rely on deeper roots for further nutrition. Mixing micronutrients with fluid fertilizers has become a popular method of application. Clear liquids are commonly used as starter fertilizers for row crops and some micronutrients, especially zinc sources, are easily applied with these fluids. Micronutrient fertilizers can provide an optimal nutrient balance, tailored to the demands of the specific crop, soil and climate conditions Agriculture micronutrients are gaining popularity globally for obtaining better yield output. The global agriculture micronutrients market value is anticipated to increase from US$ 6,576.9 Mn in 2015 to US$ 13,344.2 MN by 2024, expanding at a CAGR of 8.3% during the forecast period (2016–2024). Increasing need for effective fertilizers due to poor soil quality and high demand for quality and uniform yield in view of the increasing population across the globe are factors anticipated to drive the growth of the agriculture micronutrients market over the forecast period. As a whole any entrepreneur can venture in this project without risk and earn profit. Few Indian major players • Abellon Agrisciences Ltd. • Agro Extracts Ltd. • Aries Agro Ltd. • Bayer Cropscience Ltd. • Champion Agro Ltd. • Coromandel Agro Products & Oils Ltd.
Plant capacity: Micronutrient Fertilizer for Fruit: 1,250 Kgs/Day Micronutrient Fertilizer for Vegetable: 750 Kgs/DayPlant & machinery: Rs.58 Lakhs
Working capital: -T.C.I: Cost of Project: 345 Lakhs
Return: 27.00%Break even: 55.00%
Add to Inquiry Add to Inquiry Basket

Oxygen and Nitrogen Gas Plant (Medical and Industrial Grade)

Limelight used oxygen derived from sources such as the barium oxide Brin process. This process was based on the production of barium peroxide by roasting barium oxide in air at 590°C, then raising the temperature to 870°C. At 870°C the peroxide formed decomposes back into oxide, releasing more or less pure oxygen which can then be cooled and compressed into steel gas cylinders. Although crude, the process was ingenious in that it required no continuous input of raw materials other than air and energy. Oxygen is non corrosive and can be contained in any common metals. However care must be taken to remove all oil, grease and other combustible material from piping and containers before putting them into oxygen service. Nitrogen gas is a compound that forms from elemental nitrogen, which is found abundantly throughout the planet’s atmosphere and in most biochemical reactions. One of nitrogen’s unique properties is its ability to form multiple bonds with various other elements and compounds. Nitrogen is the chemical element with the symbol N and atomic number 7. It was first discovered and isolated by Scottish physician Daniel Rutherford in 1772, nitrogen is the principal gas in air (78%). Its first major industrial use lay in the manufacture of ammonia, used within the chemical industry as an intermediate for many compounds but especially nitrogenous fertilisers. In the combustion process, the oxygen in air is broken down to make carbon dioxide, water, and energy. Nitrogen is not an essential part of the process. In fact, nitrogen in air has negative impacts on combustion processes. Nitrogen gets heated by the reaction to very high combustion temperatures and is carried out through the flue. Essentially, the heated nitrogen leaving the flue is like throwing fuel out of the stack. Nitrogen blanketing is used to protect flammable or explosive solids and liquids from contact with air. Certain chemicals, surfaces of solids and stored food products have properties that must be protected from degradation by the effects of atmospheric oxygen and moisture. Protection is achieved by keeping these items in a nitrogen atmosphere. India industrial gases market was valued at $ 2.1 billion in 2017 and is forecast to grow at a CAGR of over 11% to surpass $ 3.9 billion in 2023 on account of growing demand from metal industry, particularly steel. As a whole any entrepreneur can venture in this project without risk and earn profit. Few Indian major players • Air Liquide India Holding Pvt. Ltd. • Arrow Oxygen Ltd. • Bellary Oxygen Co. Pvt. Ltd. • Bhagawati Oxygen Ltd. • Bhilai Oxygen Ltd. • Govind Poy Oxygen Ltd. • Howrah Gases Ltd. • Linde India Ltd.
Plant capacity: 3200 cumtrs/DayPlant & machinery: Rs. 183 Lakhs
Working capital: -T.C.I: Cost of Project: Rs. 675 Lakhs
Return: 26.00%Break even: 50.00%
Add to Inquiry Add to Inquiry Basket

Lithium Ion (LiFePO4) Cell Manufacturing

The Lithium Iron Phosphate Battery (LiFePO4 battery) or LFP Battery (lithium ferrophosphate), is a type of lithium-ion battery using LiFePO4 as the cathode material (on a battery this is the positive side), and a graphitic carbon electrode with a metallic backing as the anode. Cylindrical lithium cells are used for high specific energy density and good mechanical stability. Li-ion batteries have a higher energy density when compared to other rechargeable batteries. Li-ion batteries are composed of four main components namely cathode, anode, electrolyte, and separator. Lithium-ion battery generates electricity because of continuous reactions of lithium Li-ion Batteries have high power capacity without being too bulky. Lithium ion batteries are thus used in electronic equipment like mobile phones and laptops, which need to operate longer between charges while consuming more power and need batteries with a much higher energy density. Memory effect refers to as the process of losing maximum energy capacity of rechargeable batteries due to repeated recharges after being only partially discharged. They are used in telecommunication equipment, instruments, portable radios and TVs, pagers. They are used to operate laptop computers and mobile phones and aerospace application. Also used in electric vehicles, cell phones, camcorders, lap-top and palmtop computers, portable electronic devices, etc. The li-ion batteries are used in cameras, calculators; they are used in cardiac pacemakers and other implantable device. They are used in telecommunication equipment, instruments, portable radios and TVs, pagers. The lithium iron phosphate batteries market, by application, is segmented on the basis of the end-users it caters. The portable segment was the largest market in 2018 owing to its increased demand from the automotive sector, which is the major demand-generating industry for lithium iron phosphate batteries. The market for lithium-ion battery in India is expected to grow at a CAGR of 34. 8% during the forecast period of 2019 – 2024. In addition to it, the lithium-ion battery has comfortable rechargeable property, lightweight, long-lasting; thus, it perfectly contributes to the electric vehicle market to grow in the forecast period. Thus, due to demand it is best to invest in this project. Few Indian major players • BYD Company Ltd. • A123 Systems LLC, • K2 Energy • Electric Vehicle Power System Technology Co., Ltd. • Bharat Power Solutions
Plant capacity: 25000 nos/dayPlant & machinery: Rs. 3618 Lakhs
Working capital: -T.C.I: Cost of Project: Rs. 4626 Lakhs
Return: 25.00%Break even: 39.00%
Add to Inquiry Add to Inquiry Basket

Production of Lithium Ion (LiFePO4) Cell batteries for electric vehicles

In today's portable electronics, two types of batteries are used: lithium-ion and lithium iron phosphate. Although they have some similarities, the high energy density, long life cycles, and protection of both are significant differences. The majority of people are familiar with lithium-ion batteries since they own a smartphone, tablet, or computer. Lithium iron phosphate is a newer type of battery that is gaining popularity in the manufacturing industry due to its low cost materials and high temperature stability. Related books:- Automobile Industry, Automotive Components & Allied Products Engine Parts, Piston, Pin, Piston Ring, Valve, Control Cable, Engine Mounting, Auto Lock, Disc Brake, Drum, Gear, Leaf Spring, Shock Absorber, Silencer, Chain, Cylinder Block, Chassis, Battery Advantages of Lithium Ion (LiFePO4) Cell batteries High energy density paves the way for even greater capacities. When fresh, there is no need to prime it for a long time. All that is required is a single daily fee. Self-discharge is less than half that of nickel-based batteries, suggesting that they have a poor self-discharge. Low Maintenance: There is no need for a periodic discharge, and there is no memory. Specialty cells can provide a large amount of current to applications like power tools. Lithium Ion (LiFePO4) Cell manufacturing process Cathode, anode, electrolyte, and separator are the four primary components of Li-ion batteries. The continuous reactions of lithium in a lithium-ion battery produce electricity. Cathode A Li-ion battery's power and voltage are determined by its cathode. Since lithium is unstable in its element form, the cathode of a Li-ion battery is lithium oxide. The frame of the cathode is held together by a thin aluminium foil, which is coated with a paste made up of active material, conductive additive, and a binder. Related project: - Lithium Ion Battery Anode The anode is also coated with an active material that allows for the reversible absorption or emission of lithium ions released from the cathode while also allowing for the flow of electric current through the external circuit. Lithium ions are contained in the anode rather than the cathode when the battery is charged. Lithium ions migrate back to the cathode via the electrolyte as the conducting wire binds the cathode to the anode in the discharge state, and electrons are isolated from lithium ions and travel along the wire, producing electricity. Electrolyte The electrolyte in a Li-Ion Battery allows the transfer of lithium ions between the cathode and the anode, as well as the movement of electrons through the wire. To allow the movement of lithium ions, an electrolyte is usually made up of chemicals with high ionic conductivity. Separator The cathode and anode determine the battery's basic efficiency, while the electrolyte and separator determine the battery's safety. By holding the cathode and anode separate, the separator serves as a physical barrier. It also prevents electrons from flowing directly through the internal microscopic hole, allowing only lithium ions to pass through. Synthetic resins such as polyethylene (PE) and polypropylene (PP) are widely used in commercialized separators (PP). Market outlook The demand for lithium iron phosphate batteries in North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America is divided into three parts: the United States, Canada, and Mexico. Germany, the United Kingdom, Italy, France, and the rest of Europe make up Europe. China, India, Japan, and the Rest of Asia-Pacific make up Asia-Pacific. Because of its proven automotive sector and rising consumer electronics demand, Asia-Pacific dominated the global market. From 2020 to 2027, the global lithium iron phosphate battery market is projected to expand at a compound annual growth rate (CAGR) of 15.2 percent. Related videos: - Renewable Energy Sector, Green Power, Solar Energy, Biofuel, Hydroelectric, Wind, Non-conventional Energy, New and Renewable Energy Govt policies On November 11, 2020, the government approved the production-linked incentive (PLI) scheme in advance chemistry cell (ACC) battery manufacturing, as well as 10 other industries. The battery strategy of the scheme aims to make producers more internationally competitive, increase exports, achieve economies of scale, and develop cutting-edge goods. This is part of an attempt to encourage the use of electric vehicles (EVs), which have been hindered in India by high battery costs and a lack of supporting infrastructure. Battery imports account for more than half of the cost of an electric vehicle in India. The government has suggested that local manufacturing facilities be built in order to minimize costs and promote competition. The government has made it clear that it wants to drive India toward clean energy and transportation, as evidenced by the ambitious target of 450 GW of renewable energy production by 2020. Apart from promoting EVs, there has been a notable drive for renewable energy to be available around the clock, which includes energy storage like ACC batteries. Market Research; - Market Research Report The proposed battery policy is output-based rather than input-based, which is one of the scheme's key features. The subsidy is based on the amount of production generated and the amount of value added by private businesses. Only private companies would be eligible for a government subsidy if they reach a 60 percent value addition within five years of the project's start date, which is when full-scale development is planned. Any new technology that emerges in the next ten years will be eligible for a subsidy as well. Next, the government has set aside 570 billion (US$7.7 billion) for the car industry over the next five years as part of the programme. In reality, ACC manufacturing industries have been allocated 180 billion (US$2.4 billion) in advance. The government would pay the producer a fixed subsidy (as determined by the private entity's bid) for a period of ten years, subject to discounting over time. Economies of scale and lower production prices will be factored into the discounting. Key Players:- • BYD Company Ltd. • A123 Systems LLC, • K2 Energy • Electric Vehicle Power System Technology Co., Ltd. • Bharat Power Solutions • OptimumNano Energy Co., Ltd. • LiFeBATT, Inc. Related Projects: - Renewable Energy, Non-conventional Energy, Solar Energy, Biofuel, Biomass Projects Tags:- #LithiumIonBattery #LithiumIonBatteryProduction #LithiumIonBatteryIndustry #LithiumIonBatteryManufacturing #ElectricVehicles #ElectricVehiclesIndustry #ElectricVehiclesProduction #ElectricalIndustry #ElectricIndustry #RenewablePower #DetailedProjectReport #businessconsultant #BusinessPlan #feasibilityReport #NPCS #entrepreneurindia #startupbusiness #ProjectReport #startup #projectconsultancy #businessopportunity #IndustryDemands #profitablebusiness #ManufacturingBusiness
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Ply Board from Poplar & Eucalyptus Wooden Logs

Ply Board is wooden made board or wooden like raw materials largely used for making ply board. There is large use of ply board nowadays in making wooden base furniture. Poplar and Eucalyptus Wooden Logs can be used for making ply board. Plywood is a building material consisting of veneers (thin wood layers or plies) bonded with an adhesive. There are two types of plywood: softwood plywood and hardwood plywood. Softwoods generally correspond to coniferous species. The most commonly used softwoods for manufacturing plywood are firs and pines. Hardwood plywood is made of hardwood veneers bonded with an adhesive. The outer layers (face and back) surround a core which is usually lumber, particleboard, or medium density fiberboard. Hardwood plywood may be pressed into panels or plywood components (e.g., curved hardwood plywood, seat backs, chair arms, etc.). Poplar wood is a species of wood most commonly used in the making of furniture, cabinets, wooden toys, plywood, etc. It is considered a hardwood, but is just about as easy to work with as pine boards or other soft woods. Poplar is a popular choice for interior work and is something that is always stocked throughout all of Builder locations. Poplar boards are white/ivory in tone with green or brown streaks running through the heartwood of the board. In addition, the wood is straight grained and uniform in texture. It has a medium density which allows paints and glues to adhere very well. Indian particle board and plywood industry dates back to the First World War. It has come a long way having grown nearly six-fold since its inception. The large producers account for 15% of the total production, producing some 38 mn sqm of plywood and blackboards. The ecological considerations had, however, placed the industry in jeopardy owing primarily to the restraints put on the use of timber. Alternate materials in form of agricultural wastes like stalks of cotton and wheat, rice husk and bagasse are slowly getting into the industry as raw material feeds. The Indian market for particle board and plywood is estimated in value terms, at over Rs 37 bn. Of the total market, particle board including medium density fiberboard (MDF board) accounts for nearly a quarter of the market. Nearly 85% of the particle board is supplied by the organized sector. Western India has emerged as the leader in the particle board segment. The Indian plywood market size reached US$ 4.5 Billion in 2019 and current Indian plywood market reached a value of INR 222.5 Billion in 2020. Plywood is manufactured by assembling thin layers of wood veneers bonded together using powerful adhesives. Global Plywood Industry reach 5 Billion by 2027, growing at a CAGR of 7.9% over the period 2020-2027. Hardwood, one of the segments analyzed is projected to grow at an 8.2% CAGR to reach US$58.8 Billion by the end of the analysis period. As a whole there is a good scope for new entrepreneur to invest in this business. Few Indian major players • Archidply Industries Ltd. • Asian Pre-Lam Inds. Pvt. Ltd. • Associate Decor Ltd. • Austin Plywood Pvt. Ltd. • Century Plyboards (India) Ltd. • Duroply Industries Ltd.
Plant capacity: Poplar Ply Board Size: 8' x 4' Thickness: 18mm:250.0 Nos. Per Day Eucalyptus Ply Board Size: 8' x 4' Thickness: 18mm:250.0 Nos. Per DayPlant & machinery: 260 Lakh
Working capital: -T.C.I: Cost of Project:536 Lakh
Return: 28.00%Break even: 63.00%
Add to Inquiry Add to Inquiry Basket

Packaged Drinking Water with PET Bottles

Humans need clean tasty and safe drinking water free from any microorganism when human is thirsty and is ready to pay substantially if need be. This is available in Pouch, Bottles and cans as per requirement of the customers. The water used for potable purposes should be free from undesirable impurities. The water available from untreated sources such as Well, Boreholes and spring is generally not hygienic and safe for drinking. Thus it is desirable and necessary to purify the water and supply under hygienic conditions for human drinking purpose. Bottled water is drinking water (e.g., well water, distilled water, mineral water, or spring water) packaged in plastic or glass water bottles. Bottled water may be carbonated or not. Sizes range from small single serving bottles to large carboys for water coolers. Bottled water is the most dynamic market of all the food and beverage industry. Mineral water is bottled under very hygienic conditions under strict quality control before being marketed. Its major use is in five star Hotels, Hospitals, tourist place, function & People houses where good quality pure water is required for potable purposes. It is marketed at places and regions where hygienic drinking water is not freely available. The bottled water industry in India witnessed a boom soon after BISLERI launched its packaged drinking water in the country. This significant growth was fueled by a surge in advertising by the industry players that "bottled water was pure and healthy" As it is being considered as healthy compare to tap water or other water sources, the people conscious about health are opt for bottled water of known brand. India's packaged bottled water industry is currently dominated by the top five players, including PARLE (BISLERI, BAILLERY), PEPSICO (AQUAFINA), COCA COLA (KINLEY), DHARIWAL (OXYRICH) AND NOURISH CO. (HIMALYAN). Apart from these other leading bottled water brands in India are: KINGFISHER, TATA WATER PLUS, QUA, BLUEFIN, OVIVO, etc. The market is expected to reach INR ~403.06 Bn by the end of 2023, from its current value of INR ~160 Bn, expanding at a compound annual growth rate (CAGR) of ~20.75% from 2018. Based on volume, the market is likely to reach ~35.53 Bn liters by 2023, expanding at a CAGR of ~18.25% from 2018 to 2023. As a whole there is a good scope for new entrepreneur to invest in this business.
Plant capacity: Packaged Drinking Water 200 ml Size Bottle:28,800 Bottles per Day Packaged Drinking Water 500 ml Size Bottle:28,800 Bottles per Day Packaged Drinking Water 1000 ml Size Bottle:38,400 Bottles per DayPlant & machinery: 306 Lakh
Working capital: -T.C.I: Cost of Project:632 Lakh
Return: 24.00%Break even: 51.00%
Add to Inquiry Add to Inquiry Basket

Information
  • One Lac / Lakh / Lakhs is equivalent to one hundred thousand (100,000)
  • One Crore is equivalent to ten million (10,000,000)
  • T.C.I is Total Capital Investment
  • We can modify the project capacity and project cost as per your requirement.
  • We can also prepare project report on any subject as per your requirement.
  • Caution: The project's cost, capacity and return are subject to change without any notice. Future projects may have different values of project cost, capacity or return.

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Page 11 of 53 | Total 523 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 .... 52 53   Next »

About NIIR PROJECT CONSULTANCY SERVICES

Hide »

NIIR PROJECT CONSULTANCY SERVICES (NPCS) is a reliable name in the industrial world for offering integrated technical consultancy services. NPCS is manned by engineers, planners, specialists, financial experts, economic analysts and design specialists with extensive experience in the related industries.

Our various services are: Detailed Project Report, Business Plan for Manufacturing Plant, Start-up Ideas, Business Ideas for Entrepreneurs, Start up Business Opportunities, entrepreneurship projects, Successful Business Plan, Industry Trends, Market Research, Manufacturing Process, Machinery, Raw Materials, project report, Cost and Revenue, Pre-feasibility study for Profitable Manufacturing Business, Project Identification, Project Feasibility and Market Study, Identification of Profitable Industrial Project Opportunities, Business Opportunities, Investment Opportunities for Most Profitable Business in India, Manufacturing Business Ideas, Preparation of Project Profile, Pre-Investment and Pre-Feasibility Study, Market Research Study, Preparation of Techno-Economic Feasibility Report, Identification and Selection of Plant, Process, Equipment, General Guidance, Startup Help, Technical and Commercial Counseling for setting up new industrial project and Most Profitable Small Scale Business.

NPCS also publishes varies process technology, technical, reference, self employment and startup books, directory, business and industry database, bankable detailed project report, market research report on various industries, small scale industry and profit making business. Besides being used by manufacturers, industrialists and entrepreneurs, our publications are also used by professionals including project engineers, information services bureau, consultants and project consultancy firms as one of the input in their research.

^ Top